Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomic-based stratification of intermediate-risk prostate cancer patients.
Zhong Q, Sun R, Aref AT, Noor Z, Anees A, Zhu Y, Lucas N, Poulos RC, Lyu M, Zhu T, Chen GB, Wang Y, Ding X, Rutishauser D, Rupp NJ, Rueschoff JH, Poyet C, Hermanns T, Fankhauser C, Rodríguez Martínez M, Shao W, Buljan M, Neumann JF, Beyer A, Hains PG, Reddel RR, Robinson PJ, Aebersold R, Guo T, Wild PJ. Zhong Q, et al. Among authors: wild pj. Life Sci Alliance. 2023 Dec 4;7(2):e202302146. doi: 10.26508/lsa.202302146. Print 2024 Feb. Life Sci Alliance. 2023. PMID: 38052461 Free PMC article.
Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology.
Zhdanovich Y, Ackermann J, Wild PJ, Köllermann J, Bankov K, Döring C, Flinner N, Reis H, Wenzel M, Höh B, Mandel P, Vogl TJ, Harter P, Filipski K, Koch I, Bernatz S. Zhdanovich Y, et al. Among authors: wild pj. BMC Bioinformatics. 2023 Jan 3;24(1):1. doi: 10.1186/s12859-022-05124-9. BMC Bioinformatics. 2023. PMID: 36597019 Free PMC article.
CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients.
Bernatz S, Elenberger O, Ackermann J, Lenga L, Martin SS, Scholtz JE, Koch V, Grünewald LD, Herrmann Y, Kinzler MN, Stehle A, Koch I, Zeuzem S, Bankov K, Doering C, Reis H, Flinner N, Schulze F, Wild PJ, Hammerstingl R, Eichler K, Gruber-Rouh T, Vogl TJ, Dos Santos DP, Mahmoudi S. Bernatz S, et al. Among authors: wild pj. Sci Rep. 2023 Jan 11;13(1):533. doi: 10.1038/s41598-023-27714-0. Sci Rep. 2023. PMID: 36631548 Free PMC article.
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses.
Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, Kennel KB, Ziegler PK, Szabó L, Bollrath J, Rieder D, Michels BE, Kress A, Bozlar M, Darvishi T, Stier S, Kur IM, Bankov K, Kesselring R, Fichtner-Feigl S, Brüne B, Goetze TO, Al-Batran SE, Brandts CH, Bechstein WO, Wild PJ, Weigert A, Müller S, Knapp S, Trajanoski Z, Greten FR. Farin HF, et al. Among authors: wild pj. Cancer Discov. 2023 Oct 5;13(10):2192-2211. doi: 10.1158/2159-8290.CD-23-0050. Cancer Discov. 2023. PMID: 37489084 Free PMC article.
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center.
Kinzler MN, Jeroch J, Klasen C, Himmelsbach V, Koch C, Finkelmeier F, Trojan J, Zeuzem S, Pession U, Reis H, Demes MC, Wild PJ, Walter D. Kinzler MN, et al. Among authors: wild pj. J Cancer Res Clin Oncol. 2023 Aug;149(9):6391-6398. doi: 10.1007/s00432-023-04603-7. Epub 2023 Feb 9. J Cancer Res Clin Oncol. 2023. PMID: 36757619
Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Mahmoudi S, Bernatz S, Ackermann J, Koch V, Dos Santos DP, Grünewald LD, Yel I, Martin SS, Scholtz JE, Stehle A, Walter D, Zeuzem S, Wild PJ, Vogl TJ, Kinzler MN. Mahmoudi S, et al. Among authors: wild pj. Clin Oncol (R Coll Radiol). 2023 May;35(5):e312-e318. doi: 10.1016/j.clon.2023.01.018. Epub 2023 Feb 1. Clin Oncol (R Coll Radiol). 2023. PMID: 36804153
238 results